Skip to content
Screener

West Pharmaceutical Services WST Common Stock Shares Issued

Common Stock Shares Issued at other companies

AptarGroup logo
AptarGroupATR
73.1M+0.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
114M-3.0%
AVT
AvantorAVTR
683.1M+0.2%
Dow logo
DowDOW
791.9M+0.8%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
409.9M-2.1%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
15M+0.2%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.78B+43.4%
Enterprise value$24.66B+44.4%
P/E43.9×+8.4×
P/S7.5×+1.6×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
(in millions, except per share data)June 30,2026December 31,2025
Commitments and contingencies (Note 16)
Equity:
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding
Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: June 30, 2026 - 75.3 million, December 31, 2025 - 75.3 million; shares outstanding: June 30, 2026 - 70.4 million, December 31, 2025 - 72.0 million18.818.8
Capital in excess of par value
Retained earnings4,624.14,374.9
Accumulated other comprehensive loss(140.4)(105.5)
Treasury stock, at cost (June 30, 2026 - 4.9 million shares, December 31, 2025 - 3.3 million shares)(1,512.3)(1,112.2)

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's common stock shares issued?
West Pharmaceutical Services (WST) reported common stock shares issued of 75.3M in Q2 2026.
How has West Pharmaceutical Services's common stock shares issued changed year-over-year?
West Pharmaceutical Services's common stock shares issued decreased by 0.0% year-over-year, from 75.3M to 75.3M.
What is the long-term trend for West Pharmaceutical Services's common stock shares issued?
Over 5 years (2020 to 2025), West Pharmaceutical Services's common stock shares issued has grown at a 0.0% compound annual growth rate (CAGR), from 75.3M to 75.3M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about West Pharmaceutical Services's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude